Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Combination of Sorafenib and Radiation for Brain Metastases and Primary Brain Tumors

This study has been completed.
Information provided by (Responsible Party):
Thomas Jefferson University ( Sidney Kimmel Cancer Center at Thomas Jefferson University ) Identifier:
First received: March 13, 2008
Last updated: October 19, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2012
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)